Novo Nordisk A/S
INSULIN DEGLUDEC FOR IMPROVEMENT OF GLYCAEMIC CONTROL AND REDUCTION OF ACUTE AND LONG-TERM DIABETES COMPLICATIONS
Last updated:
Abstract:
The present invention relates to insulin degludec for use in medicine.
Status:
Application
Type:
Utility
Filling date:
28 Nov 2017
Issue date:
11 Jun 2020